Neuroendocrine system response modulates oxidative cellular damage in burn patients.
Oxygen-derived free radicals play important roles in pathophysiological processes in critically ill patients, but the data characterizing relationships between radicals and neuroendocrine system response are sparse. To search the cue to reduce the oxidative cellular damage from the point of view of neuroendocrine system response, we studied the indicators of neuroendocrine and inflammatory responses excreted in urine in 14 burn patients (42.3 +/- 31.4 years old, and 32.3 +/- 27.6% burn of total body surface area [%TBSA]) during the first seven days post burn. The daily mean amounts of urinary excretion of 8-hydroxy-2'-deoxy-guanosine (8-OHdG), a marker of oxidative cellular damage, were above the upper limit of the standard value during the studied period. The total amount of urinary excretion of 8-OHdG in the first day post burn correlated with burn severity indices: %TBSA (r = 0.63, p = 0.021) and burn index (r = 0.70, p = 0.008). The daily urinary excretion of 8-OHdG correlated with the daily urinary excretion of norepinephrine and nitrite plus nitrate (NOx) during the studied period except day 2 post burn, and correlated with the daily urinary excretion of 17-hydroxycorticosteriod (17-OHCS) in days 2, 3, and 7 post burn. These data suggest that oxidative cellular damage correlates with burn severity and neuroendocrine system response modulates inflammation and oxidative cellular damage. Modulation of neuroendocrine system response and inflammation in the treatment in the early phase of burn may be useful to reduce the oxidative cellular damage and to prevent multiple organ failures in patients with extensive burn.
Xie
Xiao-Qi
XQ
Division of Emergency Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Shinozawa
Yotaro
Y
Sasaki
Junichi
J
Takuma
Kiyotsugu
K
Akaishi
Satoshi
S
Yamanouchi
Satoshi
S
Endo
Tomoyuki
T
Nomura
Ryosuke
R
Kobayashi
Michio
M
Kudo
Daisuke
D
Hojo
Nobuko
N
D015065:17-Hydroxycorticosteroids / Q000652:urine; D000080242:8-Hydroxy-2'-Deoxyguanosine; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002056:Burns / Q000378:metabolism* / Q000473:pathology / Q000652:urine; D002648:Child; D002675:Child, Preschool; D004249:DNA Damage; D003849:Deoxyguanosine / Q000031:analogs & derivatives* / Q000652:urine; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009490:Neurosecretory Systems / Q000378:metabolism*; D009566:Nitrates / Q000652:urine; D009638:Norepinephrine / Q000652:urine
D015065:17-Hydroxycorticosteroids; D009566:Nitrates; D000080242:8-Hydroxy-2'-Deoxyguanosine; D003849:Deoxyguanosine; D009638:Norepinephrine